A randomized, double blind, parallel group, active-controlled, multi-center, 14 week study to evaluate the effectiveness of a valsartan versus an amlodipine treatment stratgey in achieving blood pressure control in patients with stage 1 or stage 2 hypertension or uncontrolled on present monotherapy
Phase of Trial: Phase IV
Latest Information Update: 10 Mar 2015
At a glance
- Drugs Valsartan (Primary) ; Amlodipine
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Novartis
- 10 Mar 2015 As EudraCT record, trial is recruiting in Spain and UK and completed in remaining countries; status retained as per NCT.
- 27 May 2011 Actual initiation date (22 Feb 2006) as reported by EudraCT.
- 27 May 2011 Actual end date (19 Jan 2007) added as reported by EudraCT (Denmark, Germany).